Literature DB >> 9690521

Loss of heterozygosity for the short arm of chromosome 7 in sporadic Wilms tumour.

R G Grundy1, J Pritchard, P Scambler, J K Cowell.   

Abstract

Cytogenetic analysis of Wilms tumours (WT) have shown that abnormalities involving chromosome 7 occur in approximately 25% of tumours. In some cases, these abnormalities involve deletions of the short arm, and are seen as the sole cytogenetic change, strongly suggesting the presence of a tumour suppressor gene in this location. Since loss of heterozygosity (LOH) studies have been crucial in defining chromosomal regions involved in Wilms tumorigenesis, we have analysed 40 sporadic Wilms tumours using a panel of 10 microsatellite polymorphic markers distributed along the length of the chromosome arm. In our series, four tumours (10%) showed allelic loss for 7p markers which is twice the background rate of LOH in WT. The shortest common region of overlap of LOH was located between markers D7S517-D7S503 in band 7p21-15. In one tumour there was evidence for a homozygous, interstitial deletion at a locus within this region. These findings provide strong evidence for the existence of a tumour suppressor gene involved in Wilms tumorigenesis and defines the critical region of the chromosome involved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690521     DOI: 10.1038/sj.onc.1201927

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Race disparities in Wilms tumor incidence and biology.

Authors:  Jason Axt; Andrew J Murphy; Erin H Seeley; Colin A Martin; Chase Taylor; Janene Pierce; Richard M Caprioli; Martin Whiteside; Harold N Lovvorn
Journal:  J Surg Res       Date:  2011-03-31       Impact factor: 2.192

2.  Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors.

Authors:  E Cristy Ruteshouser; Stephen M Robinson; Vicki Huff
Journal:  Genes Chromosomes Cancer       Date:  2008-06       Impact factor: 5.006

3.  Analysis of wilms tumors using SNP mapping array-based comparative genomic hybridization.

Authors:  Lesleyann Hawthorn; John K Cowell
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

4.  Loss of heterozygosity at 7p in Wilms' tumour development.

Authors:  R M Powlesland; A K Charles; K T Malik; P A Reynolds; S Pires; M Boavida; K W Brown
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

5.  Germline mutations and somatic inactivation of TRIM28 in Wilms tumour.

Authors:  Benjamin J Halliday; Ryuji Fukuzawa; David M Markie; Richard G Grundy; Jackie L Ludgate; Michael A Black; Jane E Skeen; Robert J Weeks; Daniel R Catchpoole; Aedan G K Roberts; Anthony E Reeve; Ian M Morison
Journal:  PLoS Genet       Date:  2018-06-18       Impact factor: 5.917

6.  CPVL promotes glioma progression via STAT1 pathway inhibition through interactions with the BTK/p300 axis.

Authors:  Hui Yang; Xiaocen Liu; Xiaolong Zhu; Xueqin Li; Lan Jiang; Min Zhong; Mengying Zhang; Tianbing Chen; Mingzhe Ma; Xiuming Liang; Kun Lv
Journal:  JCI Insight       Date:  2021-12-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.